X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://pharmaphorum.com/news/smart-sensor-cleared-use-az-asthma-copd-inhalers
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-19-2023-37838.pdf
https://www.fiercepharma.com/marketing/astrazeneca-fresh-airsupra-approval-mounts-dual-campaigns-discuss-inflammation-asthma
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200
https://www.prnewswire.com/news-releases/cipla-issues-voluntary-nationwide-recall-of-six-batches-of-albuterol-sulfate-inhalation-aerosol-90-mcg-200-metered-inhalation-due-to-container-defect-301871677.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-albuterol-sulfate-and-ipratropium-bromide-72110.pdf
https://endpts.com/after-akorns-site-closures-in-the-us-albuterol-remains-in-shortage/
https://www.fiercepharma.com/manufacturing/ah-nuts-akorns-downfall-threatens-extend-us-shortage-asthma-med-albuterol
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-revises-ceiling-prices-of-128-formulations/articleshow/97033906.cms
https://www.fiercepharma.com/pharma/astrazenecas-first-class-rescue-inhaler-airsupra-wins-fda-nod-only-adult-use
https://www.silive.com/news/2022/12/fda-these-4-drugs-are-currently-in-short-supply-in-the-us.html
https://www.fiercebiotech.com/biotech/yes-no-maybe-fda-panel-delivers-mixed-verdict-astrazenecas-asthma-rescue-medication
https://www.business-standard.com/article/news-cm/zydus-cadila-receives-usfda-final-approval-for-albuterol-tablets-120102300480_1.html
https://www.fiercepharma.com/pharma/astrazeneca-chalks-up-double-win-for-novel-combo-asthma-rescue-inhaler
https://www.pharmatimes.com/news/az_builds_case_for_fixed-dose_albuterol_and_budesonide_combo_in_asthma_1376449
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207085
https://www.prnewswire.com/news-releases/sandoz-in-licenses-brand-and-authorized-generic-of-respiratory-medicine-proventil-hfa-albuterol-sulfate-inhalation-aerosol-from-kindeva-drug-delivery-with-immediate-generic-availability-in-us-301248668.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214531
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208884
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213524
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-30-2020-1601482956.pdf
https://www.business-standard.com/article/markets/cipla-surges-5-on-ufda-approval-for-dimethyl-fumarate-dr-capsules-120092500551_1.html
https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-perrigos-voluntary-albuterol-inhaler-recall
https://www.prnewswire.com/news-releases/perrigo-voluntarily-recalls-albuterol-sulfate-inhalation-aerosol-reaffirms-2020-guidance-301133148.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209954
https://www.moneycontrol.com/news/business/lupin-gets-usfda-nod-for-asthmatic-symptoms-prevention-drug-5751941.html
https://www.livemint.com/companies/news/lupin-gets-us-fda-approval-for-generic-of-blockbuster-respiratory-drug-proair-11598339538170.html
http://www.pharmafile.com/news/557274/us-approves-new-generic-treat-people-suffering-respiratory-conditions
https://www.healthindustryhub.com.au/pharmaceutical-news-trends/new-ventolin-inhalers-with-dose-counter-reimbursed-on-the-pbs/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206532
https://www.biospace.com/article/releases/teva-announces-availability-of-proair-digihaler-albuterol-sulfate-117-mcg-inhalation-powder-for-patients-with-asthma-and-copd/
https://globalnews.ca/news/6833811/health-canada-shortage-salbutamol-inhalers-coronavirus-covid-19/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209959
https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-commonly-used-albuterol-inhaler-treat-and-prevent-bronchospasm
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-gets-final-approval-from-usfda-for-albuterol-sulfate-inhalation-aerosol/articleshow/75061892.cms
https://www.prnewswire.com/news-releases/fda-approves-first-generic-of-a-commonly-used-albuterol-inhaler-to-treat-and-prevent-bronchospasm-301037682.html
https://www.moneycontrol.com/news/trends/health-trends/cipla-gets-usfda-nod-for-asthma-inhalation-drug-albuterol-sulfate-aerosol-5124841.html
https://www.recipharm.com/press/recipharm-supports-fda-approval-perrigo%E2%80%99s-ab-rated-generic-product
https://en.globes.co.il/en/article-Perrigo-launches-generic-version-of-Tevas-ProAir-1001319766
Market Place
Share 
